Overview

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Patients With Ulcerative Colitis (UC)

Status:
Terminated

Trial end date:
2021-07-22

Target enrollment:

Participant gender:

Summary

The principal aim of this study is to evaluate the safety and tolerability of RO7049665 in participants with active ulcerative colitis.

Phase:

Phase 1

Details

Lead Sponsor:

Hoffmann-La Roche